The global Sustained Release Injectables market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
It is a preparation with better therapeutic effect by delaying drug release rate from the formulation and reducing drug absorption rate into the body.
Sustained Release Injectables Market aims to provide a comprehensive presentation of the global market for Sustained Release Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sustained Release Injectables. Sustained Release Injectables Market contains market size and forecasts of Sustained Release Injectables in global, including the following market information:
Global Sustained Release Injectables Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Microparticles Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Sustained Release Injectables include AntriaBio, Ascendis Pharma, AstraZeneca, Aurobindo, Avadel, Alkermes, Amylin Pharmaceuticals, Biomarin and Camurus, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sustained Release Injectables companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sustained Release Injectables Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Sustained Release Injectables Market Segment Percentages, by Type, 2022 (%)
- Microparticles
- Implants
- Gels
Global Sustained Release Injectables Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Sustained Release Injectables Market Segment Percentages, by Application, 2022 (%)
- Diabetes
- Leukemia
- Acromegaly
- Ophthalmology
- CNS
- Rheumatology
- Oncology
- Reproductive Health
- Others
Global Sustained Release Injectables Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Sustained Release Injectables Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Sustained Release Injectables revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Sustained Release Injectables revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AntriaBio
- Ascendis Pharma
- AstraZeneca
- Aurobindo
- Avadel
- Alkermes
- Amylin Pharmaceuticals
- Biomarin
- Camurus
- Critical Pharmaceuticals
- Durect
- Eli Lilly
- Enzon
- Ipsen
- InnoCore Pharmaceuticals
- Janssen
- Merck
- NanOlogy
- Novartis
- Oakwood Laboratories/PharmaSophia
- OctoPlus
- Pacira
- PhaseBio Pharmaceuticals
- Recipharm AB
- Roche
- Sanofi
- Taiwan Liposome Company (TLC)
- Xbrane Biopharma
- Livzon Pharm
- Luye Pharma Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sustained Release Injectables, market overview.
Chapter 2: Global Sustained Release Injectables market size in revenue.
Chapter 3: Detailed analysis of Sustained Release Injectables company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sustained Release Injectables in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Industry Market Size
